`
Wednesday, 28 June 2017

Generics News

  • Multiple organzations join hands to curb fake drug business

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market and has joined hands with 11 new organizations to strengthen its glo...Read more

  • Arvind sets up $42.37 mn plant top tap US market

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013

    Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company has invested $42.37 million to set up a new manufacturing facility at ...Read more

  • Lilly strengthens its foothold in China

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012

    Singapore, June 15, 2012:  In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans to increase its network of manufacturing capabilities in the country ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Industry body expresses concern over Nexavar decision

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012

    The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology industry in India, reacted sharply to India's grant of a compulsory li...Read more

  • US FDA approves Suprax 400 mg by Lupin

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012

    Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more

  • Tiyanyin pharma all set for GMP inspection

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Simcere, Zhuhai enter share transfer agreement

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

  • New CoolPal Vertos Advance launched by Pelican BioThermal

    Generics |  News | By Vipul Murarka | 0 Comment | 19 Jan, 2017

    US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-controlled packaging solutions serving the life sciences industry has r...Read more

  • CEPI board meeting with a focus on identifying disease priorities and future strategy

    Generics |  News | By Raj Gunashekar | 0 Comment | 19 Dec, 2016

    The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more

  • Mediven gets Frost & Sullivan Entrepreneurial Company of the Year award

    Generics |  Influencers | By Raj Gunashekar | 0 Comment | 08 Jun, 2016

    Singapore: German drug major Merck has recently inaugurated its Euro 170 million Nantong pharmaceutical plant in China, which is dedicated to producing high-quality pharmaceuticals on China...Read more

  • Mediven gets Frost & Sullivan Entrepreneurial Company of the Year award

    Generics |  Influencers | By Raj Gunashekar | 0 Comment | 15 Jun, 2016

    IMS Institute for Healthcare Informatics, a research driven entity that provides key policy setters and decision makers in the global health sector with transformational insights into healt...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls